Navigating Tricky Confidentiality and Conflicts Issues in the New Biosimilars Exchange Process

4:30-5:30 PM ET | June 7, 2013 | New York

MBHB Partner Kevin Noonan, Ph.D. is a featured presenter at this one-hour ACI-sponsored program.

Program Overview:

• 
  
  Complying with confidentiality mandates during the dossier exchange process
  
  
  
  
  • 
    
    How do you use the information that you get access to during the patent dance?
    
    
  • 
    
    Maintaining required confidentiality while remaining a zealous advocate for your company or client
  
  
• 
  
  Avoiding conflicts of interest as the lines between branded companies and generic companies blur in the biosimilars space
  
  
  
  
  • 
    
    Will the arguments you made in one case come back to haunt you in another?
    
    
  • 
    
    Applying traditional conflicts analysis and principals when agreeing to work for a client

This program is being conducted as part of the American Conference Institute’s (“ACI”) 4th Annual Conference on “Biosimilars: The Definitive Forum on the Legal, Regulatory and Commercial Realities of Biosimilars.”

Sponsored by: American Conference Institute

View complete details including registration at http://www.americanconference.com/2013/823/biosimilars/overview